申请人:Pfizer Inc.
公开号:US20030187053A1
公开(公告)日:2003-10-02
The invention relates to triamide MTP/ApoB inhibitors of the formula 1
1
wherein R
1
-R
8
are as defined in the specification, as well as pharmaceutical compositions and uses thereof, and processes for preparing the compounds. The compounds of the invention are useful for the treatment of obesity and lipid disorders.
本发明涉及三酰胺MTP/ApoB抑制剂,其化学公式为1,其中R1-R8如说明书所述,以及包含这些化合物的药物组合物及其用途,以及制备这些化合物的方法。本发明的化合物可用于治疗肥胖和脂质紊乱。